Merck & Co. evaluating MK-1654 in phase I/II study in healthy preterm and full-term infants Sep. 14, 2018
Bone Therapeutics reports final data from phase I/IIa study of ALLOB in delayed-union fractures Sep. 14, 2018
New sphingolipid-biased phenotypic approach for the discovery of new targets and new leads Sep. 14, 2018
Ozalin becomes the first oral pediatric sedative to receive marketing authorization in Europe Sep. 14, 2018
Identification of a mosquito salivary gland protein that partially limits malaria transmission Sep. 14, 2018
RSS